Evidence map›Paper›PMID 24671751›Full record

ArticleThe Journal of general virology2014

Palmitoylation is required for intracellular trafficking of influenza B virus NB protein and efficient influenza B virus growth in vitro.

Andrew Demers, Zhiguang Ran, Qiji Deng, Dan Wang, Brody Edman, Wuxun Lu, Feng Li

Abstract read
In one paragraph

Article in The Journal of general virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Palmitoylated COX-2Journal of advanced research · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Acylation - A New Means to Control Traffic Through the Golgi.Frontiers in cell and developmental biology · 2019
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Andrew DemersCenter for Infectious Disease Research and Vaccinology, South Dakota State University, Brookings, SD 57007, USA.
Zhiguang RanCenter for Infectious Disease Research and Vaccinology, South Dakota State University, Brookings, SD 57007, USA.
Qiji DengCenter for Infectious Disease Research and Vaccinology, South Dakota State University, Brookings, SD 57007, USA.
Dan WangCenter for Infectious Disease Research and Vaccinology, South Dakota State University, Brookings, SD 57007, USA.
Brody EdmanCenter for Infectious Disease Research and Vaccinology, South Dakota State University, Brookings, SD 57007, USA.
Wuxun LuCenter for Infectious Disease Research and Vaccinology, South Dakota State University, Brookings, SD 57007, USA.
Feng LiCenter for Infectious Disease Research and Vaccinology, South Dakota State University, Brookings, SD 57007, USA.
South Dakota State University · US

Funding

Mechanism of action of an HIV-1 maturation inhibitorK02AI076125 · NIAID · SOUTH DAKOTA STATE UNIVERSITY · PI LI, FENG · 2008 to 2012
$491k
NIAID NIH HHS AI0781775NIAID NIH HHS K02 AI076125NIAID NIH HHS K02AI076125-02
6 · The paper itself

Abstract

All influenza viruses bud and egress from lipid rafts within the apical plasma membrane of infected epithelial cells. As a result, all components of progeny virions must be transported to these lipid rafts for assembly and budding. Although the mechanism of transport for other influenza proteins has been elucidated, influenza B virus (IBV) glycoprotein NB subcellular localization and transport are not understood completely. To address the aforementioned properties of NB, a series of trafficking experiments were conducted. Here, we showed that NB co-localized with markers specific for the endoplasmic reticulum (ER) and Golgi region. The data from chemical treatment of NB-expressing cells by Brefeldin A, a fungal antibiotic and a known chemical inhibitor of the protein secretory pathway, further confirmed that NB is transported through the ER-Golgi pathway as it restricted NB localization to the perinuclear region. Using NB deletion mutants, the hydrophobic transmembrane domain was identified as being required for NB transport to the plasma membrane. Furthermore, palmitoylation was also required for transport of NB to the plasma membrane. Systematic mutation of cysteines to serines in NB demonstrated that cysteine 49, likely in a palmitoylated form, is also required for transport to the plasma membrane. Surprisingly, further analysis demonstrated that in vitro replication of NBC49S mutant virus was delayed relative to the parental IBV. The results demonstrated that NB is the third influenza virus protein to have been shown to be palmitoylated and together these findings may aid in future studies aimed at elucidating the function of NB.

Indexed as

Amino Acid SubstitutionAnimalsCell MembraneChlorocebus aethiopsCOS CellsCysteineEndoplasmic ReticulumGenes, ViralGolgi ApparatusInfluenza B virusLipoylationMutagenesis, Site-DirectedProtein Structure, TertiaryProtein TransportViral ProteinsVirus ReplicationCysteineNB glycoprotein, Influenza B virusViral Proteins

Identifiers

PMID24671751
PMCPMC4027035
OpenAlexW2042314624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.